7.94

0.00% 0.00

Pre-market: 7.92 -0.02 -0.25%

Lifeward Ltd (LFWD)

Overview News Price History Discussions Forecast

Lifeward Ltd stock is traded at $7.94, with a volume of 6,781. It is up +0.00% in the last 24 hours and up +9.52% over the past month. Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.

Previous Close:

$7.94

Open:

$7.98

24h Volume:

6,781

Relative Volume:

0.54

Market Cap:

$22.35M

Revenue:

$22.03M

Net Income/Loss:

$-19.91M

P/E Ratio:

-0.4289

EPS:

-18.5137

Net Cash Flow:

$-16.84M

1W Performance:

+12.62%

1M Performance:

+9.52%

6M Performance:

+13.73%

1Y Performance:

-47.90%

1-Day Range:

$7.4789

$7.98

1-Week Range:

$6.3972

$7.9996

52-Week Range:

$4.14

$15.18

Lifeward Ltd Stock (LFWD) Company Profile

Name

Lifeward Ltd

Sector

Healthcare (1106)

Industry

Medical Devices (143)

Phone

15082511154

Address

2 CABOT ROAD, HUDSON

Employee

Twitter

Next Earnings Date

2026-05-15

Latest SEC Filings

LFWD's Discussions on Twitter

Compare LFWD vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LFWD Lifeward Ltd	7.94	22.35M	22.03M	-19.91M	-16.84M	-18.51
ABT Abbott Laboratories	85.60	150.32B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	305.09	117.93B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	73.81	97.02B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	48.31	72.99B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.47	49.50B	6.30B	1.07B	1.09B	1.8406

Lifeward Ltd Stock (LFWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-10-25	Initiated	Laidlaw	Buy
Apr-03-17	Downgrade	Barclays	Equal Weight → Underweight
Dec-16-16	Initiated	Oppenheimer	Outperform
Jul-15-16	Initiated	Piper Jaffray	Overweight
May-22-15	Upgrade	Canaccord Genuity	Hold → Buy
May-08-15	Reiterated	Barclays	Equal Weight
Oct-07-14	Initiated	Barclays	Equal Weight

View All

Lifeward Ltd Stock (LFWD) Latest News

May 26, 2026

H.C. Wainwright Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $10 - Moomoo

May 26, 2026

May 23, 2026

Lifeward (LFWD) Q4 2025 Earnings Transcript - AOL.com

May 23, 2026

May 22, 2026

LFWD Technical Analysis | Trend, Signals & Chart Patterns | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill

May 22, 2026

May 21, 2026

Lifeward’s Earnings Call Balances Setbacks and Strategy - The Globe and Mail

May 21, 2026

May 20, 2026

Lifeward (Nasdaq: LFWD) posts wider Q1 loss, adds Oratech and new convertible debt - Stock Titan

May 20, 2026

Lifeward (LFWD) Chief Medical Officer receives 15,000-share RSU award - Stock Titan

May 20, 2026

Lifeward (LFWD) Chief Medical Officer discloses 2,083 ordinary shares - Stock Titan

May 20, 2026

Lifeward Ltd. Appoints Keith D. Rose, M.D. as Chief Medical Officer – SEC 8-K Filing May 2026 - Minichart

May 20, 2026

May 19, 2026

Lifeward promotes Keith Rose to chief medical officer By Investing.com - Investing.com Nigeria

May 19, 2026

Lifeward appoints Keith D. Rose, M.D. as chief medical officer By Investing.com - Investing.com Australia

May 19, 2026

How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions - Yahoo Finance

May 17, 2026

May 16, 2026